[Development of new mixing method of Busulfex injection for the purpose of improvement of medical safety method: the prefilled syringe method].
暂无分享,去创建一个
K. Dan | A. Dobashi | M. Senoo | K. Tajika | Shirou Katayama | Y. Dobashi | H. Shimizu | Masaki Hamada
[1] J. Wingard,et al. Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[2] Juan F. Martínez,et al. Stability of busulfan injection admixtures in 5 % dextrose injection and 0.9% sodium chloride injection , 1996 .
[3] J. Klein,et al. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen , 1987 .
[4] R. Brookmeyer,et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. , 1983, The New England journal of medicine.
[5] P. Feit,et al. 4-Methanesulfonyloxybutanol: hydrolysis of busulfan. , 1973, Journal of pharmaceutical sciences.
[6] I. Krämer,et al. Untersuchungen zur Stabilität der Busulfan-Stammlösung (Busilvex®, Busulfex™) in BIBraun Injekt® Einmalspritzen , 2006 .
[7] S. Eksborg,et al. Pharmacokinetic and metabolic studies of high-dose busulphan in adults , 2004, European Journal of Clinical Pharmacology.
[8] G. Vassal,et al. Pharmacokinetics of high-dose busulfan in children , 2004, Cancer Chemotherapy and Pharmacology.